PineBridge Investments’s Bio-Rad Laboratories Class A BIO Stock Holding History

PineBridge Investments’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,449	Closed	-$596K	–	574
2025 Q1	$596K	Buy	+2,449	New	+$737K	﹤0.01%	649
2024 Q4	–	Sell	-4,207	Closed	-$1.41M	–	713
2024 Q3	$1.41M	Sell	4,207 -364	-8%	-$116K	0.01%	590
2024 Q2	$1.25M	Sell	4,571 -2,365	-34%	-$688K	0.01%	411
2024 Q1	$2.4M	Buy	6,936 +1,656	+31%	+$545K	0.02%	404
2023 Q4	$1.7M	Buy	5,280 +1,395	+36%	+$437K	0.02%	391
2023 Q3	$1.39M	Buy	+3,885	New	+$1.5M	0.02%	407
2022 Q4	–	Sell	-36	Closed	-$15K	–	729
2022 Q3	$15K	Hold	36	–	–	﹤0.01%	685
2022 Q2	$18K	Buy	+36	New	+$18.7K	﹤0.01%	679
2020 Q4	–	Sell	-33	Closed	-$17K	–	657
2020 Q3	$17K	Buy	+33	New	+$16.7K	﹤0.01%	619
2015 Q1	–	Sell	-42,657	Closed	-$5.14M	–	1097
2014 Q4	$5.14M	Buy	42,657 +3,710	+10%	+$427K	0.19%	136
2014 Q3	$4.42M	Buy	+38,947	New	+$4.61M	0.18%	141

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

FPA

First Pacific Advisors El Segundo, California $8.09B AUM 21.95% 1-Year Est. Return

PineBridge Investments's BIO Position: Q2 2025 in Review

PineBridge Investments sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2025, closing a stake of 2,449 shares — an estimated $596K sold.

PineBridge Investments first reported a position in BIO in Q3 2014 and held it in 11 quarters. The position peaked at $5.14M in Q4 2014. 384 funds tracked by Wall St. Rank hold BIO as of Q2 2025.

PineBridge Investments reported no remaining Bio-Rad Laboratories Class A position as of Q2 2025 after selling out during the quarter.
PineBridge Investments sold 2,449 Bio-Rad Laboratories Class A shares in Q2 2025, an estimated $596K.
PineBridge Investments first reported a position in Bio-Rad Laboratories Class A in Q3 2014 and held it in 11 quarters.
PineBridge Investments's Bio-Rad Laboratories Class A position peaked at $5.14M in Q4 2014.
384 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2025.

Based on PineBridge Investments's 13F filing for Q2 2025, filed 13 Aug 2025.